Catch up with our regular roundup.

Global University Venturing’s regular news roundup on university innovation, business, venture funds, and more.

 

Owlstone knocks the breath out of cancer

Cambridge University spin-out Owlstone is set to trial cancer diagnostic test kits in NHS hospitals.

 

OrganoClick looks to cleanup on Nasdaq

Sweden-based cleantech firm OrganoClick sets sights on initial public offering on Nasdaq First North.

 

$335m fund emerges from endowments

Multiple university endowments back Emergence Capital Partners fourth fund, worth $335m.

 

Dublin sets parameters for space

University College Dublin spin-out Paramater Space wins ESA contract to design 3D map of the Milky Way.

 

AuraSense extends series C to $18m

AbbVie and Abbott-backed biotechnology developer AuraSense closed the $13.6m firs tranche of the round in June last year.

 

IBM researches South Africa

Tech giant IBM partners Witswatersrand on joint research and incubator hub in Johannesburg.

 

Vaxxas injected with $20m

Queensland life sciences spin-out Vaxxas secures A$25m ($20m) for needleless injection technologies.

 

Biolin licenses Nanion

Stockholm-based Biolin Scientific Holding signs licensing agreement with Munich spin-out Nanion.

 

Hopkins puts Scottish enterprise spotlight on Dundee

Andrew Hopkins, professor and spin-out founder from Dundee University, picks up entrepreneurial business leadership prize.

 

DigiSight sees GE for $7.8m series B

General Electric’s corporate venturing arm has participated in the Stanford remote patient monitoring company’s $7.8m round.

 

Woodford looks for £200m launch

Well known UK early stage investor Neil Woodford announces plans to launch £200m investment trust in April.

 

Cambridge names Jennings replacement

Paul Seabright named as successor to Richard Jennings at Cambridge University’s tech transfer office.

 

BP accelerates on Masdar’s energy

BP allies with Masdar Institute of Science and Technology on energy accelerator.

 

Quantum leap for genome sequencing

Tokyo University joins consortium backing ¥2.4 billion ($20.5m) venture round into genome sequencer firm Quantum Biosystems.